학술논문
Phase 1 Trial of Human IL-15 (rhIL-15) and Obinutuzumab for Relapsed and Refractory Chronic Lymphocytic Leukemia
Document Type
Abstract
Author
Source
In Blood 13 November 2019 134 Supplement 1:3052-3052
Subject
Language
ISSN
0006-4971